LV-Lut-Zea Vision
Natural health product licensed in Canada
- Other names
- Lut-Zea Vision
- Licence holder
- Fabrication JAMP Pharma Inc. / JAMP Manufacturing Inc.
- NPN or DIN-HM
- 80087751
- Status
- Inactive licence
- Licence date
- 13 August 2018
- Revision date
- 30 August 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Euphrasia officinalis Source : Plante Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 400 mg | 40 milligramme | Not calculated |
| Sélénium Source : Citrate de sélénium | 50 microgrammes | Not calculated |
| Tagetes erecta Source : Fleur Potency : 0.5 mg Zeaxanthin | 50 milligramme | Not calculated |
| Zinc Source : Citrate de zinc | 5 milligramme | 10,000 µg |
Non-medicinal ingredients
Maltodextrine, Hypromellose, Stéarate de magnésium, Cellulose microcristalline, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Provides antioxidants for the maintenance of eye health. Helps to maintain eyesight in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Helps to reduce the risk of developing cataracts. Helps to improve macular pigment optical density. Helps to support peripheral circulation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding.
- Effets indésirables connus
Do not use if you are allergic to plants of the Asteraceae/Compositae/Daisy family. Hypersensitivity is known to occur, in which case discontinue use. May cause confusion, headache, weakness or fatigue.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant, breastfeeding, or taking medications for diabetes, high blood pressure, or seizures.
Source
Official Health Canada record, licence 80087751
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging